Correlation between annual change in health status and computer tomography derived lung density in subjects with 1-antitrypsin deficiency
Open Access
- 1 December 2003
- Vol. 58 (12), 1027-1030
- https://doi.org/10.1136/thorax.58.12.1027
Abstract
Background: There is increasing recognition that questionnaires of health status and lung density measurements are more sensitive tools for assessing progression of emphysema than forced expiratory volume in 1 second (FEV1) and transfer coefficient (Kco). A study was undertaken to investigate prospectively the correlation between annual change in health status and computer tomography (CT) derived lung density in subjects with α1-antitrypsin deficiency. Methods: Twenty two patients of mean (SD) age 40.7 (9.2) years with ZZ type α1-antitrypsin deficiency were investigated at baseline and 30 months later by FEV1 and Kco, St George Respiratory Questionnaire (SGRQ), and by a spiral CT scan of the chest. CT data of chest images were analysed using software designed for automated lung contour detection and lung density measurements. The density data were corrected for changes in inspiration levels. Results: Changes in lung density, expressed as 15th percentile point or relative area below –950 HU, correlated well with changes in health status (SGRQ total score): R = −0.56, p = 0.007 or R = 0.6, p = 0.003. Neither changes in health status nor changes in lung density correlated significantly with changes in FEV1 or changes in Kco. Conclusions: The SGRQ total score (which is a global measure in COPD) and lung density (a specific measure of emphysema) are sensitive to deterioration in patients with α1-antitrypsin deficiency. This finding may facilitate future studies with new drugs specific for emphysema, a frequently occurring component of COPD.Keywords
This publication has 16 references indexed in Scilit:
- Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in α1-Antitrypsin Deficiency and Factors Associated with DeclineAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Alpha-1-antitrypsin deficiency: what next?Thorax, 2000
- A Randomized Clinical Trial of α1-Antitrypsin Augmentation TherapyAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)European Respiratory Journal, 1999
- Quality of life changes in COPD patients treated with salmeterol.American Journal of Respiratory and Critical Care Medicine, 1997
- Comparison of computed density and microscopic morphometry in pulmonary emphysema.American Journal of Respiratory and Critical Care Medicine, 1996
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- CT Measurements of Lung Density in Life Can Quantitate Distal Airspace Enlargement—An Essential Defining Feature of Human EmphysemaAmerican Review of Respiratory Disease, 1988
- The natural history of chronic airflow obstruction.BMJ, 1977
- Pulmonary Emphysema and Alpha1‐Antitrypsin DeficiencyActa Medica Scandinavica, 1964